Published in Proc Natl Acad Sci U S A on May 31, 2007
The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol (2014) 2.99
The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol (2011) 1.62
Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins. Proc Natl Acad Sci U S A (2009) 1.30
Binding of the molecular chaperone αB-crystallin to Aβ amyloid fibrils inhibits fibril elongation. Biophys J (2011) 1.16
The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation. Biophys J (2010) 1.15
The structured core domain of αB-crystallin can prevent amyloid fibrillation and associated toxicity. Proc Natl Acad Sci U S A (2014) 1.11
Characterization of the nucleation barriers for protein aggregation and amyloid formation. HFSP J (2007) 1.04
Observation of spatial propagation of amyloid assembly from single nuclei. Proc Natl Acad Sci U S A (2011) 1.04
Direct observation of heterogeneous amyloid fibril growth kinetics via two-color super-resolution microscopy. Nano Lett (2013) 1.02
A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates. PLoS Comput Biol (2008) 1.02
Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility. Proc Natl Acad Sci U S A (2011) 1.01
Protein solubility and protein homeostasis: a generic view of protein misfolding disorders. Cold Spring Harb Perspect Biol (2011) 0.96
Thermodynamic perspective on the dock-lock growth mechanism of amyloid fibrils. J Phys Chem B (2009) 0.95
A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation. PLoS Comput Biol (2009) 0.94
Perturbation of the stability of amyloid fibrils through alteration of electrostatic interactions. Biophys J (2011) 0.94
Population of nonnative states of lysozyme variants drives amyloid fibril formation. J Am Chem Soc (2011) 0.93
Protein Folding and Mechanisms of Proteostasis. Int J Mol Sci (2015) 0.93
Electrostatic effects in filamentous protein aggregation. Biophys J (2013) 0.93
Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding. Proteins (2009) 0.89
A generic crystallization-like model that describes the kinetics of amyloid fibril formation. J Biol Chem (2012) 0.88
Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomics. Chem Rev (2015) 0.88
C-terminal interactions mediate the quaternary dynamics of αB-crystallin. Philos Trans R Soc Lond B Biol Sci (2013) 0.88
Influence of specific HSP70 domains on fibril formation of the yeast prion protein Ure2. Philos Trans R Soc Lond B Biol Sci (2013) 0.87
The growth of sickle hemoglobin polymers. Biophys J (2011) 0.87
Relationship between prion propensity and the rates of individual molecular steps of fibril assembly. J Biol Chem (2011) 0.85
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation. Nat Commun (2016) 0.84
Association thermodynamics and conformational stability of beta-sheet amyloid beta(17-42) oligomers: effects of E22Q (Dutch) mutation and charge neutralization. Biophys J (2010) 0.83
Interactions between amyloidophilic dyes and their relevance to studies of amyloid inhibitors. Biophys J (2010) 0.83
Connecting macroscopic observables and microscopic assembly events in amyloid formation using coarse grained simulations. PLoS Comput Biol (2012) 0.80
Nucleation of polymorphic amyloid fibrils. Biophys J (2015) 0.78
Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity. Front Mol Neurosci (2017) 0.75
Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design. Interface Focus (2017) 0.75
AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species. Curr Pharm Des (2016) 0.75
Accelerated insulin aggregation under alternating current electric fields: Relevance to amyloid kinetics. Biomicrofluidics (2015) 0.75
Oligomers of Heat-Shock Proteins: Structures That Don't Imply Function. PLoS Comput Biol (2016) 0.75
Living with water stress: evolution of osmolyte systems. Science (1982) 17.27
Protein folding and misfolding. Nature (2003) 14.92
Structure of the cross-beta spine of amyloid-like fibrils. Nature (2005) 11.56
Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol (1997) 7.27
The physical basis of how prion conformations determine strain phenotypes. Nature (2006) 4.77
Therapeutic approaches to protein-misfolding diseases. Nature (2003) 4.57
The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci U S A (2002) 4.08
Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature (2005) 3.86
Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J (1999) 3.72
Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta (2004) 3.69
The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci (2001) 3.65
The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry (1996) 3.42
Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry (1999) 2.87
A naturally occurring protective system in urea-rich cells: mechanism of osmolyte protection of proteins against urea denaturation. Biochemistry (1997) 2.79
Techniques to study amyloid fibril formation in vitro. Methods (2004) 2.65
Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci U S A (2006) 2.46
Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry (2000) 2.37
Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci (2000) 2.23
Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J Mol Biol (2005) 2.14
Monomer adds to preformed structured oligomers of Abeta-peptides by a two-stage dock-lock mechanism. Proc Natl Acad Sci U S A (2006) 2.01
Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol (1999) 1.82
Direct observation of Abeta amyloid fibril growth and inhibition. J Mol Biol (2004) 1.82
Thermodynamics of A beta(1-40) amyloid fibril elongation. Biochemistry (2005) 1.81
Temperature dependence of amyloid beta-protein fibrillization. Proc Natl Acad Sci U S A (1998) 1.78
Games played by rogue proteins in prion disorders and Alzheimer's disease. Science (2003) 1.61
Kinetics of different processes in human insulin amyloid formation. J Mol Biol (2006) 1.48
Is Congo red an amyloid-specific dye? J Biol Chem (2001) 1.48
Lens alpha-crystallin: chaperone-like properties. Methods Enzymol (1998) 1.46
AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin. Biochem J (2005) 1.41
Partially folded intermediates in insulin fibrillation. Biochemistry (2003) 1.38
Optical measurement of transverse molecular diffusion in a microchannel. Biophys J (2001) 1.38
Aqueous urea solution destabilizes Abeta(16-22) oligomers. Proc Natl Acad Sci U S A (2004) 1.34
Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J Biol Chem (2004) 1.33
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc Natl Acad Sci U S A (2005) 1.31
Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy. J Mol Biol (2004) 1.24
Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency. Am J Respir Cell Mol Biol (2001) 1.17
Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. J Neurochem (1998) 1.09
Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance. Biochemistry (2002) 1.08
Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry. Protein Sci (2000) 1.00
A toy model for predicting the rate of amyloid formation from unfolded protein. J Mol Biol (2005) 1.00
Optical microscopy of growing insulin amyloid spherulites on surfaces in vitro. Biophys J (2005) 0.84
Amyloid-like green birefringence in cytoskeletal 10 nm filaments after staining with Congo red. Acta Pathol Microbiol Scand A (1979) 0.81
Convenient method for monitoring Abeta aggregation by quartz-crystal microbalance. Chem Biol Drug Des (2006) 0.77
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Simultaneous determination of protein structure and dynamics. Nature (2005) 5.28
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med (Berl) (2003) 5.15
Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature (2003) 4.98
The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci U S A (2002) 4.08
Long-range interactions within a nonnative protein. Science (2002) 4.06
Protein structure determination from NMR chemical shifts. Proc Natl Acad Sci U S A (2007) 3.96
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
Amyloid formation by globular proteins under native conditions. Nat Chem Biol (2009) 3.72
High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2004) 3.58
Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell (2012) 3.39
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol (2005) 3.18
Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc (2005) 3.13
Role of intermolecular forces in defining material properties of protein nanofibrils. Science (2007) 2.94
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR. Nature (2004) 2.84
The importance of sequence diversity in the aggregation and evolution of proteins. Nature (2005) 2.70
De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci U S A (2002) 2.59
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J (2002) 2.59
Prediction of aggregation-prone regions in structured proteins. J Mol Biol (2008) 2.56
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci U S A (2006) 2.46
Molecular recycling within amyloid fibrils. Nature (2005) 2.39
Kinetic partitioning of protein folding and aggregation. Nat Struct Biol (2002) 2.37
Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol (2007) 2.35
Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc Natl Acad Sci U S A (2002) 2.18
Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J Mol Biol (2009) 2.14
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol (2004) 2.14
Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc Natl Acad Sci U S A (2003) 1.93
Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci (2006) 1.89
Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci (2007) 1.88
Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A (2004) 1.83
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A (2002) 1.80
The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J (2007) 1.79
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc Natl Acad Sci U S A (2013) 1.75
Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proc Natl Acad Sci U S A (2010) 1.72
From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol (2012) 1.71
Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput Biol (2007) 1.71
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature (2003) 1.66
Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat Struct Biol (2002) 1.64
Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. Structure (2005) 1.63
The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol (2011) 1.62
Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Proc Natl Acad Sci U S A (2008) 1.56
Nanobodies raised against monomeric α-synuclein distinguish between fibrils at different maturation stages. J Mol Biol (2013) 1.56
Exploring amyloid formation by a de novo design. Proc Natl Acad Sci U S A (2004) 1.55
Intermolecular structure determination of amyloid fibrils with magic-angle spinning and dynamic nuclear polarization NMR. J Am Chem Soc (2011) 1.54
Metastability of native proteins and the phenomenon of amyloid formation. J Am Chem Soc (2011) 1.53
Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J Chem Phys (2011) 1.52
Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy. Biochemistry (2010) 1.50
ANS binding reveals common features of cytotoxic amyloid species. ACS Chem Biol (2010) 1.48
Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem (2005) 1.48
Determination of a transition state at atomic resolution from protein engineering data. J Mol Biol (2002) 1.47
A coupled equilibrium shift mechanism in calmodulin-mediated signal transduction. Structure (2008) 1.45
Determination of an ensemble of structures representing the denatured state of the bovine acyl-coenzyme a binding protein. J Am Chem Soc (2004) 1.44
Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci (2004) 1.44
In situ measurements of the formation and morphology of intracellular β-amyloid fibrils by super-resolution fluorescence imaging. J Am Chem Soc (2011) 1.37
The formation of spherulites by amyloid fibrils of bovine insulin. Proc Natl Acad Sci U S A (2004) 1.36
Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J (2002) 1.35
Protein misfolding and disease: from the test tube to the organism. Curr Opin Chem Biol (2008) 1.35
Mimicking phosphorylation of alphaB-crystallin affects its chaperone activity. Biochem J (2007) 1.34
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc Natl Acad Sci U S A (2005) 1.31
Heteronuclear NMR investigations of dynamic regions of intact Escherichia coli ribosomes. Proc Natl Acad Sci U S A (2004) 1.31
Structural biology. Dynamic visions of enzymatic reactions. Science (2006) 1.30
Structure and dynamics of a ribosome-bound nascent chain by NMR spectroscopy. Proc Natl Acad Sci U S A (2007) 1.30
A highly amyloidogenic region of hen lysozyme. J Mol Biol (2004) 1.29
Rare fluctuations of native proteins sampled by equilibrium hydrogen exchange. J Am Chem Soc (2003) 1.27
Calculation of mutational free energy changes in transition states for protein folding. Biophys J (2003) 1.27
Formation of native and non-native interactions in ensembles of denatured ACBP molecules from paramagnetic relaxation enhancement studies. J Mol Biol (2005) 1.27
Protein folding on the ribosome. Curr Opin Struct Biol (2010) 1.25
Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem (2003) 1.25
Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J (2005) 1.25
Dye-sensitized solar cell based on a three-dimensional photonic crystal. Nano Lett (2010) 1.24
High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: backbone conformation and implications for protofilament assembly and structure . Biochemistry (2010) 1.24
Label-free detection of amyloid growth with microcantilever sensors. Nanotechnology (2008) 1.24
Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. J Chem Phys (2011) 1.23
The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. J Am Chem Soc (2014) 1.22
A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea. Protein Sci (2002) 1.22
Three-dimensional structures of translating ribosomes by Cryo-EM. Mol Cell (2004) 1.21
Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J Mol Biol (2004) 1.21
Determination of the free energy landscape of alpha-synuclein using spin label nuclear magnetic resonance measurements. J Am Chem Soc (2009) 1.21
Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation. Proc Natl Acad Sci U S A (2009) 1.21
Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep (2013) 1.20
Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol (2005) 1.19
Nanostructured films from hierarchical self-assembly of amyloidogenic proteins. Nat Nanotechnol (2010) 1.19